• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Eton Pharmaceutcials Inc (NQ: ETON )

    4.590 -0.020 (-0.43%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 25,787
    Open 4.630
    Bid (Size) 3.120 (1)
    Ask (Size) 4.670 (12)
    Prev. Close 4.610
    Today's Range 4.537 - 4.630
    52wk Range 3.030 - 5.810
    Shares Outstanding 25,688,062
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference
    From Eton Pharmaceuticals
    Via GlobeNewswire
    ETON Stock Earnings: Eton Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024
    ETON stock results show that Eton Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    N/A
    N/A
    1 Month
    +31.14%
    +31.14%
    3 Month
    +26.10%
    +26.10%
    6 Month
    +2.23%
    +2.23%
    1 Year
    +6.74%
    +6.74%

    More News

    Read More
    Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results
    From Eton Pharmaceuticals
    Via GlobeNewswire
    Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
    From Eton Pharmaceuticals
    Via GlobeNewswire
    Recap: Eton Pharmaceuticals Q4 Earnings
    Via Benzinga
    Eton Pharmaceuticals Earnings Preview
    Via Benzinga
    Is NASDAQ:ETON suited for growth investing?
    Via Chartmill
    SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
    Via ACCESSWIRE
    Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)
    From Eton Pharmaceuticals
    Via GlobeNewswire
    ETON Stock Earnings: Eton Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    Eton Pharmaceuticals Reports First Quarter 2024 Financial Results
    From Eton Pharmaceuticals
    Via GlobeNewswire
    Why the growth investor may take a look at NASDAQ:ETON.
    Via Chartmill
    Evaluating NASDAQ:ETON for Growth Investment Opportunities.
    Via Chartmill
    Eton Pharmaceuticals: Q3 Earnings Insights
    Via Benzinga
    Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference
    From Eton Pharmaceuticals
    Via GlobeNewswire
    Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)
    From Eton Pharmaceuticals
    Via GlobeNewswire
    Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
    From Eton Pharmaceuticals
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria
    From Eton Pharmaceuticals
    Via GlobeNewswire
    ETON Stock Earnings: Eton Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023
    Via InvestorPlace
    Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
    From Eton Pharmaceuticals
    Via GlobeNewswire
    Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024
    From Eton Pharmaceuticals
    Via GlobeNewswire
    Earnings Scheduled For March 14, 2024
    Via Benzinga
    Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation
    From Eton Pharmaceuticals
    Via GlobeNewswire
    Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules
    From Eton Pharmaceuticals
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.